Cognitive & Nootropic Peptide Reference
Peptides that target cognitive function through neurotrophic, neuroprotective, or neuromodulatory mechanisms — from synthetic ACTH analogs (Semax) to multi-peptide brain extracts (Cerebrolysin) and experimental cognitive enhancers (Dihexa).
Cognitive & Nootropic Peptides (6)
Cerebrolysin
EVER Neuro Pharma
A porcine brain-derived peptide preparation containing low-molecular-weight neuropeptides and free amino acids, approved in over 40 countries for stroke recovery and traumatic brain injury.
Dihexa
Research-Grade
A hexapeptide analog of angiotensin IV that crosses the blood-brain barrier and promotes synaptogenesis via hepatocyte growth factor (HGF) signaling — studied for cognitive enhancement and neurodegenerative disease.
GPE (Glycine-Proline-Glutamate)
Research-Grade
A naturally occurring tripeptide cleaved from the N-terminus of IGF-1 in the brain, studied as a neuroprotective agent in stroke and neurodegeneration models.
NA-Selank Amidate
Research-Grade
An N-acetylated, amidated analog of Selank with improved metabolic stability and enhanced CNS bioavailability — studied for anxiolytic and nootropic effects.
Selank
Research-Grade
A synthetic heptapeptide analog of tuftsin, developed at the Russian Institute of Molecular Genetics as an anxiolytic nootropic administered intranasally.
Semax
Research-Grade
A synthetic heptapeptide fragment of ACTH (4-10) developed in Russia as a cognitive enhancer, used clinically there for stroke recovery and anxiety.